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The mechanism(s) by which CTL kill their targets remains controversial (1). Two
majorhypotheses havebeen advanced as models for target cellcytolysis. Thegranule
exocytosis model, for which we (2) and others (3, 4) have provided evidence, pro-
poses that preformed lytic mediators that exist in secretory granules are released
bythe cytotoxic lymphocyte upon stimulus ofan effector cell receptor by the target
cell. One important granule-associated lytic mediator that has been well character-
ized is cytolysin or perforin, a protein that induces lysis by formation of pores in
the target cell membrane. An alternative model that has been proposed to account
for lymphocyte cytotoxicity is the internal disintegration model (5), in which the
CTLinducesanautolytic mechanism in the target; i.e., theultimate lytic mediators
are derivedfrom the target cell. This model derives from the observationthat target
cell DNA is released from the nucleus before lysisduring lymphocyte-mediated cy-
totoxicity (5, 6). This phenomenon occurs during programmed cell death (7-11) as
well as during cytotoxicity by both CTL and NK cells (5, 6, 12), but has not been
observed when cells are killed by osmotic lysis or with complement. Recent reports
have indicated thepossibility thatthe disruptionofion gradients inthe plasma mem-
brane ofsome target cells, usingvalinomycin(13), staphylococcala-toxin, orpurified
perforin (14), is sufficient for the induction of DNA release.
The discovery thatCTLsecretory granules containlarge amountsofseveral unique
serine proteases (15-19) has raised questions as to their function. While inhibition
ofcytotoxicity by serine esterase inhibitors has been interpreted as evidence that
these enzymes are a necessary component ofthe cytolytic mechanism (20-23), the
natural substrates for these enzymes remain unknown. By sequence analysis, CTL
granule serine proteases appear to belong to a family of granule enzymes (gran-
zymes) (19) that also include those found in granules of mast cells and neutrophils
(24). There appears to benofirmly established physiologicalfunction forthe granule
proteases in any ofthese cells. We have recently shown that inhibition ofgranzyme
A activity in CTL granules does not significantly reduce the lytic activity ofthese
cells (25).
We have recently considered the possibility that several lymphocyte granulecom-
ponents can contribute to target cell damage, particularly DNA fragmentation and
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release (26). We have shownthat granules, isolated from large granular lymphocytes
(LGL) 1 and CTL, can mediate target cell DNA release from 1251-UdR-labeled
target cells. Purified cytolysin induces "Cr release, but not DNA release, from
double-labeled target cells. While granules with inactivated cytolysin could induce
neither "Cr nor 1251-DNA release, addition of purified cytolysin to such granules
restored the release of both "Cr and DNA (26). These data suggested that a medi-
ator(s) of DNA release was present in the granules, but was active only if provided
access to the nucleus of the target cell. We present evidence here that the prominent
CTL granule protease granzyme A (alternatively referred to as Hannukah factor,
T cell-specific protease 1, SE-1, or BLTesterase) is a potent mediator of DNA break-
down in permeabilized target cells.
Materials and Methods
Cell Lines.
￿
The mouse CTL clone BM10.37 (H-2Kbm"' anti-H-2K6) has been described
(27). Cloned CTL were maintained by weekly stimulation with irradiated B10 spleen cells
and cultured in RPMI supplemented with 10% FCS and with 2% rat T cell Polyclone (Col-
laborative Research Inc., Bedford, Mass.) and 20 U/ml rIL-2. EL-4 lymphoma cells were
cultured in RPMI/10% FCS and passed in fresh medium 1 d before use as target cells.
Inactivation ofGranule Proteases in Intact CTL.
￿
Cloned CTL were harvested, washed in HBSS,
and divided into six equal aliquots. Two groups each were initially treated with medium alone,
10 mM NH4C1, or 3 pg/ml monensin at 37°C for 30 min. PMSF (1 mM) or DMSO (sol-
vent control) was then added to one of each of the three treatment groups for an additional
30 min at 37'C . The CTL were washed three times and added to wells with double-labeled
EL-4 lymphoma target cells ("Cr and ' 251-UdR; Amersham Corp., Arlington Heights, IL)
at the indicated E/T ratios. Release ofeach of the isotopes was determined after4 h at 37°C.
12'I-DNA release was measured after termination of the assay with Triton X-100 (0.3%).
SubcellularFractionation ofCTL.
￿
BM10.37 CTL were harvested, washed in HBSS, suspended
in disruption buffer (0.25 M sucrose, 4 mM EGTA, 10 mM Hepes, pH 7.4), and subjected
to nitrogen cavitation as previously described (28). Nuclei were removed by centrifugation
at 500g for 10 min . The cavitate was then layered onto a 52% Percoll (Pharmacia Fine Chem-
icals, Piscataway, NJ) gradient and subjected to centrifugation at 29,000 rpm for 26 min using
a Beckman 50.2Ti rotor in a Beckman L5-75B ultra-centrifuge (Beckman Instruments,
Fullerton, CA). Fractions (0.8 ml) were collected from the bottom of the tube and analyzed
for cytolysin, BLTesterase, and nuclear DNA-releases (NDR) activities (see below). Active
fractions were pooled and frozen until further use.
Cytolysin, BLTEsterase, and NDR Assays.
￿
Cytolysin activity was measured as previously
described (29), using sheep erythrocytes as targets. 1 U/ml is defined as that concentration
required to cause 50% lysis of sheep erythrocyte targets at 37°C in 10 min. BLTesterase
activity was measured using a modification (24) of the method of Pasternak and Eisen (15).
1 U/ml BLTesterase activity is that concentration that produces an OD of 1.0 at 414 nm
in 30 min at 25°C. NDR activity was measured using Triton X100-permeabilized EL-4 target
cells labeled with 1251-UdR (26). Briefly, 5 x 106 EL-4 cells were harvested in logarithmic
growth and incubated with 50 p,Ci of 125I-UdR in a volume of 0.5 ml for 2 h at 37"C. La-
beled cells were then washed and incubated for an additional hour at 37°C before use. Granules
or column fractions were diluted in PBS containing 0.6% Triton X-100. An equal volume
of target cells in HBSS containing 1 mg/ml BSA was then added to the diluted samples in
a 96-well plate. The plates were incubated for 2 h at 37°C, afterwhich they were centrifuged
at 400 g to pellet the nuclei. The upper 100 pl of supernatant fluid was then harvested for
counting in a Micromedic ME Plus gamma spectrometer (Micromedic Systems, Inc., Hor-
sham, PA). 1 U/ml is defined as that concentration that causes 50% of maximal release of
1251-DNA under these conditions.
' Abbreviations used in this papa: LGL, large granular lymphocytes; NDR, nuclear DNA-releasing.HAYES ET AL.
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Immunoabsorption Experiments.
￿
Antibodies were produced by immunization of rabbits with
granzyme A that was purified by sequential gel filtration and heparin-agarose chromatog-
raphy from LGL densegranules. This preparation migrated as a single band under reducing
and nonreducing conditions by silver stain of SDS polyacrylamide gels. For immunoabsorp-
tion, 100 p,l packed protein A-Sepharose was incubated for 1 h at room temperature with
100 kl of rabbit antisera. The beads were washed with PBS and resuspended with a soluble
extract of CTL light granules for 1 h at room temperature. The beads were centrifuged and
the resulting supernatant fluid was tested for NDR and BLTesterase activities.
Purification of Cytolysin.
￿
Cytolysin was purified from pooled dense granules derived from
Percol gradients of rat RNK tumor cell homogenates. Briefly, granules were solubilized by
suspension in 2 M NaCl followed by centrifugation at 100,000 g for 90 min. The soluble
extract was fractionated by gel filtration on an AcA54 column (Pharmacia Fine Chemicals)
equilibrated in phosphate-buffered 2 M NaCl, 0.5 mM EGTA, 0.2% polyethylene glycol (PEG)
pH 7.4, dialyzed exhaustively into PBS, and further purified by heparin-agarose chromatog-
raphy. The latter column was equilibrated in PBS, 0.2 % PEG, and the cytolysin activity was
eluted with 0.45 M NaCl. This preparation was homogeneous by silver stain of SDS poly-
acrylamide gels and contained no detectable BLTesterase activity.
Purification ofBLTEsterase.
￿
BLTesterase and NDR activities were solubilized from pooled
active fractions of Percoll gradients of CTL nitrogen cavitates by the addition of solid NaCl
to a final concentration of 2 M. The mixture was rapidly freezed-thawed twice and subjected
to centrifugation at 100,000 g for 60-90 min to remove insoluble material. This extract was
loaded onto a 2.5 x 100 cm AcA54 column equilibrated with 10 mM Hepes, pH 7.0, 1 M
NaCl, 0.2% PEG. 5-ml fractions were collected and assayed for BLTesterase and NDR ac-
tivities. Peak fractions were pooled and loaded directly onto an aprotinin-Sepharose column
(1.0 x 18 cm), equilibrated in the same buffer with 0.2 M NaCl. aprotinin-Sepharose was
prepared by coupling aprotinin (Trasylol; BoehringerMannheim Biochemicals, Indianapolis,
IN) to cyanogen bromide-activated Sepharose (Pharmacia Fine Chemicals)according to the
manufacturer's instructions. The aprotinin column was washed with equilibration buffer and
activity was eluted with 0.1 M acetate buffer, pH 3 .0, containing 0.2 M NaCl and 0.2 % PEG.
Eluted fractions were immediately neutralized with 1 M Tris-HCI, pH 7.5, assayed for ac-
tivity, pooled, and dialyzed exhaustively against the original equilibration buffer. Protein
concentrations were determined by the bicinchoninic acid procedure (BCA assay; Pierce Chem-
ical Co., Rockford, IL). Purified material was stored at -70'C until further use.
Results
Inhibition ofTarget Cell DNAReleaseby Pretreatment ofCTLwith PMSF andAgents That
Raise the pH of Intracellular Compartments. Previous studies have shown that treat-
ment of CTL with the serine esterase inhibitor PMSF reduced their BLTesterase
activity significantly; this effect was markedly enhanced when PMSF was added in
the presence ofagents that are known to raise the pH of acidic intracellular Compart-
ments by different mechanisms, ammonium chloride (NH4C1) and monensin (24).
Since PMSF is known to react optimally with serine esterases at neutral pH, the
interpretation of this result is that the BLTesterase activity in CTL resides in an
acidic intracellular compartment. The ability of CTL to lyse targets was affected
only slightly by pretreatment of the effectors with these reagents, consistent with
a lack of involvement of granule serine proteases in lytic activity. We have extended
these studies to ask if target cell DNA release is affected by the same treatments.
CTL were pretreated with combinations of PMSF and NH4C1 or monensin,
washed, and incubated with EL-4 lymphoma target cells that had been labeled with
"Cr and "'I-UdR (Fig. 1). As previously found (25), none of the treatments had
a substantial effect on the capacity of theseeffectors to lyse target cells, as measured
by "Cr release (Fig. 1, top). However, pretreatment with the combination ofPMSF
with either NH4C1 or monensin resulted in a significant decrease in the capacity936
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FIGURE 1.
￿
Inactivation of granule proteases
of intact CTL inhibits tar et cell 1211-DNA
release without affecting 5 Cr release. CTL
(clone 37)were pretreated as describedinMa-
terials andMethodsandincubatedwith dou-
ble-labeled EL-4 lymphomatarget cells. After
4 h, "Cr release(top) and 1251-DNA release
(bottom) were determined. 1251-DNA release
was measured by terminating the assaywith
Triton X-100(final concentration, 0.3%) to re-
leaseDNAtrappedin anymembranous com-
partment. Treatments ofCTLwereas follows:
control(squares), NH4C1(diamonds), monensin
(triangles), PMSF (+), NH4C1 and PMSF (x),
monensin and PMSF (inverted triangles).
ofthe CTL to induce target cell DNA release (Fig. 1, bottom). These results imply
that a serine protease residing in an acidic intracellular compartment of the CTL
is involved in target cell DNA release. Therefore, further studies were designed to
identify potentialmediatorsofthisactivity, and to assess the potential roleofgranule
proteases in DNA release.
Subcellular Compartmentalization ofBLTEsteraseandNDRActivities.
￿
We have reported
that both LGL and CTL contain an activity, whichhas been termed nuclear DNA-
releasing activity, that is present in distinct subcellularcompartments afterfraction-
ation of effector cell homogenates over Percoll gradients (26). This NDR activity
is defined by the induction ofrelease of1251-DNA from Triton X-100-permeabilized
target cells (see Materials and Methods). Homogenates ofcloned CTL were exam-
ined to identify compartments within the cells that contained the nuclear DNA-
releasing activity and to assess its association with BLTesterase activity. After alow
speed centrifugation to remove nuclei, the homogenates were fractionated by den-
sity overa52% self-forming Percoll gradient, asdescribed inMaterials and Methods.
In Fig. 2, profiles from representative gradients are shown for NDR and BIT-
esterase activities. The majority of both activities are present in "light granule"
fractions, 19-26, which also contained most of the membranous material in these
gradients, with amuch smallerpeak associated with previously characterized dense
granules (fractions 1-5, which contain cytolysin activity) (28, 29). These activities
always comigrated inPercoll gradients, although the ratio ofdense to light granular
material varied among preparations.
Effects on Activities by Esterase Inhibitors.
￿
Previous experiments in our laboratory
haddemonstrated that LGL dense granule-derived NDR activity was inhibited byBENZAANWNE (log uM)
APRO71NIN (log ng/ml)
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serine esterase-reactiveagents suchas diisopropyl fluorophosphate (DFP)andPMSF
(26). NDR activity from the light granules of cloned CTL is also sensitive to
micromolar concentrations ofPMSF (data not shown). Inhibition profiles ofCTL
light granule-derived NDR and BLTesterase activities were determined usingtwo
additional esterase inhibitors, benzamidine and aprotinin. Virtually identical profiles
were derivedwith benzamidine, with 50% inhibitionoccuring at0.79 and 0.71 mM
for BLTesterase and NDR activities, respectively (Fig. 3, top). However, when the
macromolecularinhibitor aprotininwasused, 50% inhibition occurred at 0.6/Ag/ml
for NDR activity and at 7.2 14g/ml for BLTesterase activity (Fig. 3, bottom).
Immunoabsorption ofNDRActivity byAnti-BLTEsteraseAntibodies.
￿
To detect any im-
munological relationship between NDR and BLTesterase activities, rabbit antisera
raised against BLTesterase purified from rat LGL tumor dense granules were used
100,
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FIGURE 2.
￿
Suboellular fractionation ofNDRand
BLTesterase activities in CTL. Clone 37 (bm10
anti-B10) CTLwere subjectedto nitrogen cavita-
tion andthecavitate wasfractionated over a52%
Percoll gradient as described in Materials and
Methods. Each fraction (0.8 ml) wasanalyzed for
NDR(solidline)andBLTesterase (dashedline) ac-
tivities afterfreeze-thawing.Active fractions were
pooled and stored for further purification.
FIGURE 3.
￿
Effect ofesterase inhibitors on NDR
and BLTesterase activities. Pooled light mem-
brane fractions(see Fig. 2) were incubatedwith
benzamidine (top)or aprotinin(bottom) at thein-
dicated concentrations and assayed for NDR
(circles)and BLTesterase (squares) activities. The
control value for NDR activity was release of
17,433 t 386 cpm of 1251-DNA. The control
value for BLTesterase activity was an OD414 of
0.930 t 0.023.938
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in immunoabsorption experiments. Protein A-Sepharose beadswere incubatedwith
rabbit antisera against BLTesterase or KLH, washed, and incubated with soluble
extracts from CTLlight granules. The supernatant, aftercentrifugation ofthebeads,
was then assayed for NDR and BLTesterase activities. Both activities were com-
pletelyabsorbed by the anti-BLTesterase butnot by the control antibody (Table I).
Purification ofNDR/BLTEsterase Activities.
￿
Since the above results suggested that
BLTesterase and NDR activity could be mediated by the same enzyme, the ac-
tivities were purified. As a first step, soluble extracts of CTL light granules were
fractionated over an AcA54 gel filtration column. The activities comigrated on this
column in a single peak at -60,000 daltons (Fig. 4). The peak fractions from this
column were pooled and immediately applied to an aprotinin-Sepharose column
in buffer containing 1 MNaCl. The column was washed in 0.2 MNaCl and eluted
with acetate buffer at pH 3. Again, the activities comigrated and eluted in a single
peak with the acid wash (Fig. 5). The effectivepurification ofthese activities is sum-
marized in Table II, which shows little change in the ratio of the two activities
throughout the purification. The affinity-purified material was analyzed by SDS-
PAGE underreducingand nonreducingconditions(Fig. 6). Underthelatter, asingle
prominent band migrating at -60,000 daltons was revealed by Coomassie blue
staining. Upon reduction, the band shifted to 30,000 daltons. These properties are
identical to those previously reported for granzyme A(19, 30); such dimeric struc-
ture is unique among known serine proteases. Further evidence that NDR activity
wasmediated bythegranzyme ABLTesterase and notbyan undetected contaminant
wasprovided by thedemonstration that NDR activity remains associatedwith BIT -
esterase during reduction and alkylation. The purified esterase was reduced and
alkylated (31) and migration ofthe two activities was measured after gel filtration
(Fig. 7). The control (treated as the experimental without the inclusion of DTT)
esterase/NDR activities migrated as before as a single peak at 60,000 daltons. The
esterase/NDR activities remained associated after reduction and alkylation, but at
the expected monomer position of 30,000 daltons.
Release of DNA from Target Cells Treated with Purified Cytolysin and BLTEsterase.
￿
It
was critical to assess the activity ofpurified BLTesterase on target cells permeabi-
TABLE I
Immunoabsorption of NDR Activity by Anti-BLT-Esterase Antibodies
Remaining activity
NDR (% release)
￿
BLT-E
ODg1q
Control AB
￿
75 .3
￿
0.553
Anti-granzyme A
￿
0.6
￿
0.003
A soluble extract prepared by suspension of CTL light granules in 2 M NaCl
was incubated with protein A-Sepharose beads coated with rabbit antisera made
against granzyme A or a control antiserum against keyhole limpet hemocyanin.
The beads were centrifuged and the resulting supernatant fluid was tested for
NDR and BLT-esterase activities. NDR activity is expressed as percent specific
1251-DNA release after 2 h at 37°C, and BLT-esterase activity is expressed as
optical density at 414 nm.w
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TABLE II
Purification of NDR/BLT-Esterase Activities from CTL
FIGURE 4.
￿
Gel filtration of solubilized
light membranous material. Pooled light
membrane fractions were solubilizedby the
m
￿
addition of2 M NaCl and centrifugation
at 100,000 g for 90 min. The soluble ma-
m
￿
terial was applied to a 2.5 x 100 cm AcA54
gel filtration column equilibrated with 10
5
￿
mM Hepes, pH 7.0, 1 M NaCI, and 0.2
PEG (see Materials and Methods). 5-ml o
￿
fractions were collected and assayed for
NDR (solid line) and BLTesterase (dashed
line) activities. The column was calibrated
with gel filtration standards BSA, oval-
bumin, chymotrypsinogen A, and ribo-
nuclease A (Pharmacia Fine Chemicals).
FIGURE 5.
￿
Aprotinin-Sepharose chromatogra-
phy ofAcA54 peak fractions. Pooled active frac-
tions from an AcA54 preparative run were added
directly to a 1 x 18 cm aprotinin-Sepharose col-
umn, which waswashed with 10 mM Hepes, 0.2 M
NaCl, and 0.2% PEG before elution (at fraction
20) with 0.1 M acetic acid, pH 3.0. Eluted frac-
tions were immediatelyneutralized with 1 M Tris-
HCl, pH 7.5, and tested for NDR (solid line) and
BLTesterase (dashed line) activities.
Specific activity
See Materials and Methods for purification steps.
t NDR activity in units per milligram; numbers in parentheses are -fold purifi-
cation.
S BLT-esterase activity in units per milligram.
II Ratio of NDR to BLT-esterase activity at each step.
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lizedwiththe pore-forming granule proteincytolysin instead ofdetergent. EL-4 target
cells were labeled with "Cr and 1251-UdR, washed and incubated in the presence
ofpurified cytolysin (fromLGLgranules, reference29) and/or purifiedBLTesterase.
In Fig. 8, EL-4 lymphoma target cells were treated for4 h with dilutions ofpurified
cytolysin alone, and specific release of "Cr and 1251-DNA was assessed. 1251-DNA
BLT-ES NDR/BLT-El
744 (1 .0) 0.919
837 (1 .1) 0.748
2,731 (3 .7) 0.572
20,694 (27 .8) 0.670
Step' NDR1
Light granules 684(l .0)
1 M NaCl extract 626 (0.9)
AcA54 peak pool 1,563 (2.3)
Aprotinin-Sepharose
eluate 13,871 (20.3)940
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FIGURE 6 .
￿
SDS-PAGE ofaprotinin-Sepharose-purifiedNDRandBLTesterase
activity. 5 Mg (BCA assay) of affinity-purified protein was resolved on a 10%
polyacrylamide gel under reducing (R) and nonreducing (NR) conditions and
the gel was stained with Coomassie blue R-250 . Molecular weight standards
(Bio-Rad Laboratories, Richmond, CA) were as follows : phosphorylase b
(97,400), BSA (66,200), ovalbumin (42,699), carbonic anhydrase (31,000), soy-
bean trypsin inhibitor (21,500), and lysozyme (14,400) .
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FIGURE 7 .
￿
Reductionand alkylation
ofesterase/NDR activities . 60,ug (1 ml)
ofpurified esterase was incubated in the
presence of 5 mM benzamidine (to
protect the active site) and 1 mM di-
thiothreitol for 1 h at 37 °C (crosses) . A
control sample was treated with ben-
zamidine only (squares) . Both samples
were then reacted with 4 mM iodoa-
cetamide for 1.5 h at 37°C, and then
dialyzed exhaustively against AcA54
running buffer (see Fig . 4) . Residual
esterase activity to the reduced sample
was -80% ofthe control.The samples
were fractionated over an AcA54 gel
filtration column as in Fig . 4, and as-
sayed for BLTesterase (top) andNDR
(bottom) activities .W
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FIGURE 8. Purified cytolysin alone in-
duces minimal DNA release. EL-4 cells
were labeled with "Cr or 1251-UdR and
exposed to dilutions of purified LGL
granule cytolysin (U/ml as assayed on
RBC) for4hat 37°C. At harvest, thecells
were pelleted andthesupernatant fluidwas
taken directly for determination of "Cr
release(filledsquares). Fordetermination of
1251-DNA release(opensquares), Triton X-
100was added to afinalconcentration of
0.3% immediately before centrifugation
and harvest.
T
200 240
FIGURE 9.
￿
Cytotoxicity mediated by purifiedcytolysin andBLTesterase. EL-4 target cells were
labeled with "Cror 1251-UdRandexposed to BLTesterase (310 ng/ml) in the presence of purified
cytolysin (20 U/ml as assayed on RBC) fortheindicated periods oftime. Specific releaseofeach
isotope (5 Cr,filled squares; 1251-DNA, open squares) was measured as in Fig. 8.
94 1
releasewas minimal at fullylyticconcentrations ofcytolysin, but adetectableamount
(20%) was released at marginally lytic concentrations. When purified granzyme A
was added totarget cellsin the presence ofpurified cytolysin at aconcentration where
no DNA release was observed with cytolysin alone (1/200), significant release of 1211_
DNAoccurred after 1 h and rose gradually over4 h (Fig. 9). However, DNA release
requiredaddition ofdetergent at harvest, indicating that itwas stilltrappedinsome
membranous compartment in the target cells. "Cr releaseoccurred within the first
15 min ofincubation, and increased gradually over 4 h under the same conditions.942
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Discussion
The studies described here provide clear evidence fora role for the CTL granule
protease granzyme A intarget cell nuclear DNA breakdown. Experimentswith PMSF
treatment of CTL indicate that their capacity to cause target cell DNA release is
dependent on a serine protease activity that resides in a low pH subcellular com-
partment (such as a secretory granule). In support ofthis functional result, wehave
shown that the nuclear DNA-releasing activity present in CTL is mediated by the
T cell-specific granule protease that has previously been identified as granzyme A
(19, 30). These results are significant both because they identify a potential mecha-
nism through which CTL can mediate target cell DNA release by way of a granule
exocytosis pathway, and because they indicate the existence offunctionally impor-
tant substrates for granzyme A.
The functional data presented in Fig. 1 suggest that a granule serine protease(s)
is involved in the release oftarget cell DNAduring CTL-mediated cytotoxicity. We
have previously shown that PMSF treatment of CTL substantially inhibits BIT-
esterase activity; this inhibition is virtually complete when PMSF is added in the
presence ofNH4Cl or monensin, agents, which raise the pH of intracellular com-
partments by independent mechanisms (24). As seen in Fig. 1 (top), the release of
"Cr from target cells is only marginally affected, suggesting that BLTesterase ac-
tivity is apparently not required for the lytic activity of these effectors. However,
the abilityofthese same effector cellsto induce target cell DNAreleasewassignificantly
reduced upon treatment with these agents. The synergistic effect of PMSF and
NH4Cl or monensin on target cell DNA release was substantial, implying that the
functionally relevant molecule(s) affected resides in an acidic intracellular compart-
ment. These results, combined with the fact that CTL-derived NDR activity was
also inhibited by serine esterase-reactive agents, led us to investigate the relation-
ship between BTL-esterase activity and NDR activity present in CTL.
The molecular identity ofNDR and BLTesterase activities was demonstrated by
physicochemical and immunological results. First, the two activities reside in the
samesubcellularcompartments, as shown by densityfractionation overPercoll gra-
dients ofCTL homogenates (Fig. 2). The secretorycapacity ofthese compartments
is difficult to demonstrate directly. However, BLTesterase has been widely used as
a secretory marker for many CTL studies. Second, NDR activity and BLTesterase
comigrate in single peaks upon gel filtration and an affinity column (aprotinin-
Sepharose). Third, the affinity-purified material is composed predominantly of a
single protein that migrates at -60,000 daltons on SDS-PAGE and, upon reduc-
tion, at 30,000 daltons. This behavior has already been described for purified gran-
zyme A, and distinguishes this enzyme from all ofthe other described granule pro-
teases (19, 30). Fourth, the two activities show similar inhibition profiles with
benzamidine and aprotinin. Aprotinin was an order of magnitude more effective
at inhibition of NDR than ofBLTesterase activity. One likely explanation for this
is that the aprotinin peptide does not compete as effectively for the BIT substrate
as for the unknown NDR substrate. The common inhibitor susceptibilities, how-
ever, strengthen the likelihood that the two activities are mediated by an identical
enzyme. An additional compelling argument for this relationship is the immuno-
logical crossreactivity ofthese activities. Both are specifically absorbed by a rabbit
antiserum madeagainst granzyme A purified by adifferent procedure from ratLGLHAYES ET AL.
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granules. Finally, when the esterase was reduced and alkylated, the activities con-
tinued to be associated when refractionated over a gel filtration column. Taken to-
gether, thesedataindicatethe identityofNDR andBLTesteraseactivities, andimply
a role for granzyme A in target cell DNA release.
Others have reported that DNA release or fragmentation can be induced by iso-
lated CTL granules (32-34). However, in two recent reports, the authors have ar-
gued that there is no DNA-releasing activity in CTL granules (35, 36). In both of
these studies, however, the granules were used at concentrations at which DNA re-
lease was not likely to be observed. We have observed elsewhere (Munger, W E.,
C. W Reynolds, and P. A. Henkart, manuscript in preparation) that, with LGL-
deriveddense granules, DNA release from detergent-permeabilized nuclei isdetected
only at concentrations greater than that required for maximal "Cr release. We
would predict, based on the data presented here, that the extent of DNA release
induced by granules would depend upon (a) the susceptibility of the target cell to
DNA degradation induced by ionic leakage, and (b) the ratio ofcytolysin to gran-
zyme A in the secretory granules. Nevertheless, we would argue that DNA release
observed when granule extracts are added to cell suspensions is inefficient with re-
spect to "Cr release compared with its delivery by intact CTL. Our reasoning is
that, when added in solution, the cytolysin, due to its amphiphilic nature in the
presence of calcium, should partition efficiently into the target cell plasma mem-
brane. Granzyme A, however, will not be subject to such influences on partitioning
to its relevant substrate(s) and suffers a dilutional effect when added in solution.
During killing by intact CTL, this inefficiency is overcome by the polarized secre-
tory mechanism that delivers a high local concentration of the active mediator(s)
to the appropriate target sites (e.g., the nucleus) within the cell.
Recent reports have indicated that DNA release can occur from various target
cellstreatedwithagents that disrupt membrane iongradients, includingvalinomycin
(13), staphylococcal a-toxin, and murine perforin (14). We observed small but de-
tectable amounts of DNA release in EL-4 targets treated with purified cytolysin,
but only at minimally lytic concentrations (Fig. 8). At higher, fully lytic concentra-
tions, no DNA release was observed. The discrepancy over cytolysin/perforin-in-
duced DNA release may be due to differences in target cells or assay conditions;
thelatter should takeinto considerationthe active concentration ofthe pore-forming
protein. Further experiments should clarify the role of cytolysin/perforin in target
cell DNA release.
Since the premise of our approach was that detergent permeabilization oftarget
nuclei couldbeused tomimic thatprovided by cytolysinreleased from CTLgranules,
it was important to demonstrate that granzyme Acan mediate DNA release from
cells permeabilized with cytolysin. Fig. 9 clearly demonstrates that granzyme A has
access to its substrate when cytolysin is present. However, the DNA releasewas not
detectable unless thecellswere furthersolublizedby terminatingthe assay withTriton
X-100, in a manneranalogous to that ofRussell and Dobos (37). This suggests that,
although granzyme Acan entercytolysin-treated cells, DNA fragments remain trapped
in some membrane-bound compartment after DNA breakdown has occurred.
The rate oftarget nuclear DNA release by granzyme A (Fig. 9) is considerably
slower than the rate of "Cr release by cytolysin or by CTL. It can thus be argued
that we have not reproduced the findings ofDNA breakdown precedinglysis which944
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gave rise to the "internal disintegration" model (5). Current studies in our labora-
tory, aimedat dissecting themolecularpathway of nuclear DNAbreakdown by gran-
zyme A, show that the rate of granzyme A induced nuclear DNA breakdown can
be increased by altering the assay conditions. We speculate that with the high local
granzyme Aconcentrations produced during granuleexocytosis, target DNAbreak-
down may occur rapidly. In any case, target cell DNA breakdown inducedby cytolysin
and granzyme A from CTL, and involving existing target cell components, would
not require de novo gene expression. This model would explain the resistance of
CTL-induced target cell DNA breakdown to inhibitors of RNA and protein syn-
thesis (12),which is in strong contrast to the results in systems undergoing programmed
cell death (7-11). Such target RNA and protein synthesis is clearly not required in
our experimental system, where lysis by detergent or cytolysin occurs very rapidly.
The mechanism by which granzyme A mediates nuclear DNA release is still un-
clear. There is no reason to expect that granzyme A has any DNase activity. Two
models can be proposed as possible means by which DNA release is mediated. (a)
Granzyme A acts upon nuclear matrix proteins to ultimately allow the accessibility
of cytosolic nucleases to the DNA and/or simply allow its release from the nucleus;
and (b) granzyme A acts upon a cytosolic substrate and activates this substrate in
a zymogen-like manner to induce DNA fragmentation. Experiments in progress
to distinguish between these possibilities favor the former model.
Summary
The rapid breakdown of target cell DNA during CTL-mediated lysis has been
difficult to explain by the granule exocytosis model of cytotoxicity. The involvement
of CTL granule proteases in this process was strongly suggested by experiments in
which CTL were pretreated with the serine protease inhibitor PMSF, in combina-
tion with agents that raisethe pH of acidic intracellular compartments. WhilePMSF
pretreatment alonehadlittle effect on target lysis or DNA breakdown, the combina-
tion of PMSF and NH4C1 or monensin profoundly reduced target cell DNA release,
while little effect was observed on target lysis, as measured by "Cr release. CTL
granule extracts cause release of 1251-DNA from detergent-permeabilized cells. This
nuclearDNA-releasing(NDR) activity is inhibited by serine esterase inhibitors that
also inhibit the granule BLTesterase activity, and is specifically immunoabsorbed
by antibodies to the CTL granule protease granzyme A. The NDR activity comi-
grates with BLTesterase activity during subcellular fractionation, solubilization, gel
filtration, and aprotinin-Sepharose affinity chromatography. SDS-PAGE analysis of
the affinity-purified product indicates a molecular mass of60,000 daltonsundernon-
reducing conditions, which movesto 30,000 daltonsupon reduction, consistent with
previously reported behavior of granzyme A. When the purified material was re-
ducedand alkylated, both esterase and NDR activities comigrated at 30,000 daltons
upon gel filtration. Although fully lytic concentrations of purified LGL granule
cytolysin alone failed to induce target cell DNA release, a combination of purified
granzyme A and the cytolysin induces substantial DNA release.
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